Richard DiMarchi - Assembly Biosciences Insider

ASMB -- USA Stock  

USD 36.55  0.17  0.46%

Dr. Richard DiMarchi is Independent Director of Assembly Biosciences, Inc. Dr. DiMarchi is a cofounder of Assembly Pharmaceuticals and has served on its board since inception in 2012. Dr. DiMarchi currently holds the Cox Distinguished Professor of Biochemistry and Gill Chair in Biomolecular Sciences at Indiana University. Dr. DiMarchi was a cofounder and board member of biotechnology companies Ambrx and Marcadia, current founder of Assembly and Calibrium Biotech, and advisor to venture firms 5AM, Twilight Ventures, and others. Dr. DiMarchi retired as Group Vice President at Eli Lilly Company, where he provided leadership for more than two decades in biotechnology, endocrine research, and product development
Age: 61  Director Since 2014  Ph.D    
DiMarchi previously served as a board member of the biotechnology trade group BIO, Isis and Millennium BioTherapeutics. His current research is focused on developing macromolecules with enhanced therapeutic properties through biochemical and chemical optimization, an approach he has termed chemicalbiotechnology.Dr. DiMarchi received his PhD in Biochemistry from Indiana University, and completed his postdoctoral studies at the Rockefeller University.

Richard DiMarchi Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (23.67) % which means that it has lost $23.67 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (53.01) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana. Assembly Biosciences operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 85 people.Assembly Biosciences (ASMB) is traded on Nasdaq Capital Markets in USA. It is located in 11711 North Meridian Street and employs 85 people.

Assembly Biosciences Leadership Team

Uri Lopatin, Vice President - Research & Development, Chief Medical Officer
Helen Kim, Independent Director
Myron Holubiak, Independent Director
Lee Arnold, Chief Scientific Officer
Anthony Altig, Independent Director
Richard Colonno, Chief Scientific Officer
Graham Cooper, CFO, COO and Principal Financial Officer and Principal Accounting Officer
William Ringo, Non-Executive Chairman of the Board
Susan Mahony, Director
Richard DiMarchi, Director
Miguel Barbosa, Chief Scientific Officer, Head of Microbiome Program
Thomas Rollins, Chief Development Officer
Mark Auerbach, Independent Director
Derek Small, Co-Founder, CEO and President and Director
Alan Lewis, Director
David Barrett, CFO, COO

Stock Performance Indicators

Did you try this?

Run Cryptocurrency Center Now

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Cryptocurrency Center

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Assembly Biosciences and Novartis AG. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.